Recruiting Migraine Studies in Stockbridge
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
The purpose of this study is to evaluate the efficacy and safety of rimegepant when administered during the peri-menstrual period (PMP) for intermittent prevention of migraine in women who experience ...
A Study of K-645 in the Treatment of Multiple Migraine Attacks
This is a multicenter, randomized, double-blind, placebo-controlled, 3-period crossover study to evaluate the safety, tolerability, and efficacy of two dose levels of K-645 in the treatment of patient...
About Migraine Clinical Trials in Stockbridge
Migraine is a neurological condition characterized by intense, debilitating headaches often accompanied by nausea, light sensitivity, and visual disturbances. It affects about 1 billion people globally and is a leading cause of disability. Treatments include preventive medications, acute therapies, and newer CGRP-targeting drugs.
There are currently 2 migraine clinical trials recruiting participants in Stockbridge, GA. These studies are seeking a combined 843 participants. Research is being sponsored by Pfizer, Kallyope Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Migraine Clinical Trials in Stockbridge — FAQ
Are there migraine clinical trials in Stockbridge?
Yes, there are 2 migraine clinical trials currently recruiting in Stockbridge, GA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Stockbridge?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stockbridge research site will contact you about next steps.
Are clinical trials in Stockbridge free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stockbridge studies also compensate for your time and travel.
What migraine treatments are being tested?
The 2 active trials in Stockbridge are testing new therapies including novel drugs, biologics, and treatment approaches for migraine.
Data updated March 2, 2026 from ClinicalTrials.gov